Improving Prescription Concentration and Generic Drug Ratios
First written in FY2017-Q2. 1 of 4 entries say "Dropped", first in FY2017. Latest entry: FY2020.
1 other company's latest entry also says "Restated".
- FY2020RestatedAnnual report
「In the dispensing business, we have worked to strengthen pharmacy functions that contribute to community healthcare, including by pursuing the Community Support System Add-on, while recommending switching to generic drugs and aiming to increase their utilization rate.」
The dispensing business continues to recommend switching to generic drugs and increasing their utilization rate as an initiative. - FY2020-Q3Reappears as an increase in the generic-drug utilization rateAnnual report
「In the dispensing business, we have worked to strengthen pharmacy functions that contribute to community healthcare, including by pursuing the Community Support System Add-on, while recommending switching to generic drugs and aiming to increase their utilization rate.」
The same theme as the previously mentioned improvement in the generic-drug ratio has been mentioned again in the form of recommending a switch to generic drugs and increasing their utilization rate. - FY2017DroppedAnnual reportThe improvement in prescription concentration and generic-drug ratios mentioned in the previous quarter is not mentioned in this filing.
- FY2017-Q2First statedAnnual report
「Prescription dispensing sales are performing steadily, supported by improvements in the prescription concentration and generic-drug ratios and by Japan’s declining birth rate and aging population.」
It states that the company is working to improve its prescription concentration and generic-drug ratios in response to the factors weighing on profit from the revision of dispensing fees.